This transcript is for your personal, non-commercial usage only. To bid presentation-ready copies for organisation to your colleagues, clients oregon customers sojourn http://www.djreprints.com.
https://www.barrons.com/articles/teva-pharmaceutical-stock-earnings-miss-51635338941
Updated Oct. 27, 2021 10:58 americium ET / Original Oct. 27, 2021 8:49 americium ET
- Order Reprints
- Print Article
Teva Pharmaceutical was falling aft the Israeli generics drugs institution missed quarterly net forecasts owed to weakness successful its U.S. generics business.
The banal roseate soon aft the markets opened Wednesday but was falling precocious by 4.47% to $8.97. The banal has fallen astir 7.5% twelvemonth to date.
Adjusted third-quarter net were 59...
/etf_analysis_proshares_ultrapro_nasdaq_biotech__ss-5bfc3af846e0fb0051c1e7d5.jpg)
English (US) ·